New antibody drug takes aim at Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing a new drug called PLT012 in adults with advanced solid tumors that have not responded to standard treatments. PLT012 is an antibody that targets a protein called CD36 found on some cancer cells. The main goals are to find safe doses and to see if…
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC